Alan B Miller Selected Research

Alan B Miller Research Topics

Disease

25	Heart Failure 01/2021 - 02/2002
4	Sudden Death 01/2021 - 07/2002
4	Myocardial Infarction 05/2013 - 01/2007
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 11/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2016 - 06/2002
2	Stroke (Strokes) 05/2013 - 03/2012
2	Atrial Fibrillation 03/2013 - 04/2005
2	Type 2 Diabetes Mellitus (MODY) 05/2010 - 08/2008
2	Hypertension (High Blood Pressure) 10/2009 - 10/2006
1	Left Ventricular Dysfunction 11/2016
1	Diabetes Mellitus 10/2015
1	Hypotension (Low Blood Pressure) 10/2015
1	Hyponatremia 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2014
1	Stomach Ulcer (Gastric Ulcer) 10/2014
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2013
1	Systolic Heart Failure 04/2013
1	Myocardial Stunning (Stunned Myocardium) 06/2012
1	Coronary Vasospasm (Coronary Artery Vasospasm) 06/2012
1	Seizures (Absence Seizure) 03/2012
1	Heart Diseases (Heart Disease) 05/2010
1	Weight Gain 05/2010
1	Edema (Dropsy) 05/2010
1	Infarction (Infarctions) 10/2009
1	Fibrosis (Cirrhosis) 10/2009
1	Anemia 05/2009
1	Death (Near-Death Experience) 08/2007
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2006
1	Atherosclerotic Plaque (Atheroma) 08/2006
1	Inflammation (Inflammations) 08/2006
1	Atherosclerosis 10/2003
1	Pathologic Constriction (Stenosis) 10/2003
1	Thromboembolism 02/2002
1	Hemorrhage 02/2002

Drug/Important Bio-Agent (IBA)

3	AldosteroneIBA 10/2009 - 04/2005
2	CreatinineIBA 10/2015 - 03/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2015 - 03/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2014 - 02/2002
2	Vasopressins (Vasopressin)IBA 12/2013 - 05/2010
2	Tolvaptan FDA Link 12/2013 - 05/2010
2	bucindololIBA 03/2013 - 01/2012
2	Glyburide (Glibenclamide)FDA LinkGeneric 05/2010 - 08/2008
2	ThiazolidinedionesIBA 05/2010 - 08/2008
2	Pioglitazone (Actos)FDA Link 05/2010 - 08/2008
2	Eplerenone (Inspra)FDA LinkGeneric 10/2009 - 01/2007
2	ElectrolytesIBA 10/2009 - 01/2007
2	Mineralocorticoid Receptor AntagonistsIBA 10/2009 - 01/2007
2	Spironolactone (Aldactone)FDA LinkGeneric 10/2009 - 01/2007
2	CholesterolIBA 08/2006 - 06/2002
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006 - 06/2002
1	tafamidisIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Prealbumin (Transthyretin)IBA 01/2021
1	RelaxinIBA 10/2014
1	Omeprazole (Prilosec)FDA LinkGeneric 10/2014
1	TabletsIBA 10/2014
1	omega-Chloroacetophenone (Mace)IBA 05/2013
1	BilirubinIBA 04/2013
1	Caffeine (No Doz)FDA LinkGeneric 06/2012
1	EnzymesIBA 06/2012
1	rolofyllineIBA 03/2012
1	Adenosine (Adenocard)FDA LinkGeneric 03/2012
1	Antidiuretic Hormone Receptor AntagonistsIBA 05/2010
1	Irbesartan FDA LinkGeneric 03/2010
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 05/2009
1	Hemoglobins (Hemoglobin)IBA 05/2009
1	Biomarkers (Surrogate Marker)IBA 08/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2007
1	LipidsIBA 10/2006
1	Carvedilol (Coreg)FDA LinkGeneric 10/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2005
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2004
1	Phenobarbital (Luminal)FDA Link 10/2003
1	DiureticsIBA 07/2002
1	Coenzyme A (CoA)IBA 06/2002
1	Warfarin (Coumadin)FDA LinkGeneric 02/2002

Therapy/Procedure

10	Therapeutics 01/2021 - 02/2002
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2016 - 07/2015
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 07/2010 - 05/2009
1	Patient Readmission 05/2010
1	Polypharmacy 05/2009
1	Length of Stay 03/2009
1	Secondary Prevention 06/2002